Patents by Inventor Heather Lawlor

Heather Lawlor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) AND VACCINES
    Publication number: 20160228536
    Abstract: Described herein is a recombinant respiratory syncytial virus (RSV) having an attenuated phenotype. In one embodiment, recombinant RSV includes an M2-2 protein with a mutation that renders the M2-2 protein inactive or prevents expression of the M2-2 protein. In one embodiment, the amino acid at position 66 in the F subunit has a positively charged side chain. Nucleic acids encoding recombinant RSV are also described, as well as vectors containing the nucleic acids.
    Type: Application
    Filed: September 11, 2014
    Publication date: August 11, 2016
    Inventors: Jeanne Schickli, Roderick Tang, Heather Lawlor
  • Expression Of Soluble Viral Fusion Glycoproteins In Mammalian Cells
    Publication number: 20140024076
    Abstract: The technology relates in part to production (i.e., expression) of recombinant viral fusion glycoproteins and nucleic acids that encode such viral fusion glycoproteins. In some embodiments, human respiratory syncytial virus fusion protein (RSV-F) and human parainfluenza virus 3 fusion protein (hPIV3-F) are expressed.
    Type: Application
    Filed: January 27, 2012
    Publication date: January 23, 2014
    Applicant: MEDIMMUNE, LLC.
    Inventors: Roderick Tang, Gregory M. Hayes, Heather Lawlor, Peifeng Chen, Yi Liu